BRIEF published on 11/14/2025 at 18:05, 1 month ago Biosynex: Grant received for a rapid preeclampsia test Public Health Grant BIOSYNEX Preeclampsia Quick Test
BRIEF published on 10/22/2025 at 18:05, 1 month 23 days ago BIOSYNEX SA: 2025 Half-Year Results and Safeguard Procedure Financial Results Turnover Financial Strategy Backup Procedure Depreciation Of Assets
BRIEF published on 09/29/2025 at 18:05, 2 months 15 days ago BIOSYNEX initiates financial restructuring and will liquidate its subsidiary AVALUN Financial Restructuring BIOSYNEX AVALUN Backup Procedure Compulsory Liquidation
BRIEF published on 09/25/2025 at 18:05, 2 months 19 days ago BIOSYNEX begins safeguard proceedings, AVALUN ceases payment Debt BIOSYNEX AVALUN Backup Procedure Cessation Of Payment
BRIEF published on 07/29/2025 at 18:50, 4 months 16 days ago Biosynex Achieves Breakthrough Device Status for Its Syphilis Test FDA Syphilis Breakthrough Device Rapid Diagnosis Chembio
BRIEF published on 07/17/2025 at 18:05, 4 months 28 days ago BIOSYNEX announces a decline in revenue for the first half of 2025 Restructuring Product Launches Turnover BIOSYNEX First Half Of 2025
BRIEF published on 05/06/2025 at 15:15, 7 months 9 days ago BIOSYNEX: Number of Shares and Voting Rights as of February 28, 2025 Share Capital Voting Rights Euronext Growth BIOSYNEX Health Diagnosis
BRIEF published on 04/23/2025 at 18:05, 7 months 21 days ago BIOSYNEX SA: 2024 Results and 2025 Reorganization Plan Financial Structure BIOSYNEX SA 2024 Results Export Growth Reorganization 2025
BRIEF published on 03/04/2025 at 18:05, 9 months 10 days ago BIOSYNEX: Declaration of the number of shares and voting rights Share Capital Voting Rights Actions BIOSYNEX Health Diagnosis
BRIEF published on 02/12/2025 at 08:05, 10 months 3 days ago BIOSYNEX successfully completes its capital increase Capital Increase Subscription BIOSYNEX Dilution Of Shareholders Oversubscription Rate
Published on 12/15/2025 at 15:00, 1 hour 4 minutes ago Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 1 hour 4 minutes ago Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 1 hour 34 minutes ago Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 14:00, 2 hours 4 minutes ago Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum
Published on 12/15/2025 at 13:30, 2 hours 34 minutes ago Greenlane Announces Results of Annual Meeting of Stockholders, Canopy Growth Co Founder Bruce Linton Joins Greenlane's Board of Directors
Published on 12/15/2025 at 15:50, 13 minutes ago Original-Research: Cabka N.V. (von First Berlin Equity Research GmbH): Kaufen
Published on 12/15/2025 at 15:49, 14 minutes ago Mutares submits an irrevocable offer to acquire Venator Ultramarine Blue Pigments business from Venator France SAS
Published on 12/15/2025 at 15:45, 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 12/15/2025 at 15:44, 19 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/15/2025 at 15:43, 20 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 12/15/2025 at 11:50, 4 hours 13 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025
Published on 12/12/2025 at 18:00, 2 days 22 hours ago Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/11/2025 at 08:30, 4 days 7 hours ago Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe
